During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many ...

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

HOPA OCC’s practice-based tools for oncology practices has the potential to improve practice adherence…by using the OAA baseline assessment, facilitate enhanced communication between patients and ...

Halting the relentless march of so-called 'zombie cells' that drive aging and age-related diseases could be a step closer ...

Special Report: Race Oncology has initiated its lead trial site Southside Cancer Care Centre in Miranda, NSW, as the first ...

The new drug development corporation Daimbio announced on the 25th that it has completed a series A funding round worth 12 ...

The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

These cancers are, however, quite sensitive to anticancer drugs such as poly (ADP-ribose) polymerase inhibitors (PARPi). When successful, these cancer treatments cause enough DNA damage to trigger ...